Vincent Chau is currently the Executive Director at Eli Lilly and Company, a role they have held since 2023. Previously, they completed their medical training as House Staff in Internal Medicine at Montefiore Health System from 2015 to 2018 and served as a Hematology/Oncology Fellow at The National Institutes of Health from 2018 to 2021. Vincent participated in the Medical Scientist Training Program at UT Southwestern Medical Center from 2007 to 2015, where they focused on identifying novel chemotherapeutic agents for malignant peripheral nerve sheath tumors. They hold an MD and PhD in Genetics and Development from the University of Texas Southwestern Medical Center at Dallas and an AB in Biological Sciences, Chemistry and Chemical Biology, and Africana Studies from Cornell University.
This person is not in any teams
This person is not in any offices